Acceptability and tolerability of a dermocosmetic kit in patients undergoing cancer treatment with dermatological adverse reactions Aceptabilidad y tolerabilidad de un kit dermocosmético en pacientes en tratamiento oncológico con reacciones adversas dermatológicas

Abstract

Adverse skin reactions secondary to antineoplastic therapy are frequent. For its treatment, in Colombia there is a dermocosmetic kit, which restores and protects the barrier function of the skin. Objective: to describe the experience of use, evolution and quality of life of cancer patients undergoing treatment, with prescription of a dermocosmetic kit. Methods: a descriptive observational study based on medical records was carried out, including patients with cancer in active treatment, who were prescribed a dermocosmetic kit. Sociodemographic data, level of xerosis, functionality and the SKINDEX-29 scale (symptoms and quality of life) were taken from the baseline consultation. From the 7-week follow-up, the clinical evolution and the experience of using the kit were documented. Descriptive analysis of the data was performed. Results: Fifty-nine patients with a diagnosis of cancer undergoing treatment, between the ages of 25 and 89, were included. On a scale of 0 to 10, ease of use, overall satisfaction, and physician satisfaction received a median score of 10. In 91.5% of patients, the level of xerosis was reduced. Pruritus measured from 0 to 100, went from a median of 75 points at the beginning of the follow-up, to a final median of 25 points. 15.3% of the patients had a severe affectation of their quality of life in the baseline measurement, and after 7 weeks of follow-up, this affectation presented in 5.1% of the patients. The most affected domain was symptoms. Conclusions: Ease of use, overall satisfaction, and physician satisfaction with the dermocosmetic kit was excellent. There was an effect in the reduction of xerosis, pruritus and the quality of life of these patients was improved.